Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-05

Clinical Trial Update: The Impact of Clinical Pharmacist Intervention and Dapagliflozin as Add-On Therapy in the Management of Type 2 Diabetes Mellitus. [NA]

View source ↗

Summary

A completed clinical trial evaluating the impact of clinical pharmacist intervention and dapagliflozin as add-on therapy in managing Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: University of Sulaimani | Conditions: Type 2 Diabetes Mellitus (T2DM) | NA | Status: COMPLETED